COVID-19 Pneumonia in a Hemodialysis Patient

Tang, Bin; Li, Sijia; Xiong, Yuwan; Tian, Ming; Yu, Jun; Xu, Lixia; Zhang, Li; Li, Zhuo; Ma, Jianchao; Wen, Feng; Feng, Zhonglin; Liang, Xinling; Shi, Wei; Liu, Shuangxin

doi:10.1016/j.xkme.2020.03.001

Cited by 68 publications

(83 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although the majority of COVID-19 pneumonia patients have normal serum procalcitonin (PCT), the patient had slightly elevated PCT on admission. Tang et al noted that PCT has limitations in hemodialysis patients with COVID-19 pneumonia because it tends to be chronically elevated in these patients [10].…”

Section: Discussionmentioning

confidence: 99%

“…The evidence on the possible efficacy of the proposed regimen for severe COVID-19 pneumonia is largely from case reports and observational studies. Lopinavir-ritonavir and Ribavirin have been used successfully as monotherapies in the treatment of mild COVID-19 pneumonia in hemodialysis patients [8,10]. In 2004, Chu et al noted a favorable clinical response with lopinavir/ritonavir and ribavirin combination in 41 SARS-CoV patients when compared with the historical outcomes of ribavirin and corticosteroids [12].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A Hemodialysis Patient with Severe COVID-19 Pneumonia

Alalwan¹,

Taher²,

Al-Aradi³

2020

Cureus

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a novel coronavirus that has spread rapidly, resulting in a worldwide pandemic. Even though end-stage renal disease (ESRD) patients are particularly susceptible to COVID-19 infection and can develop severe to critical disease, there are limited studies and case reports about COVID-19 in ESRD patients. We report a case of a 63-year-old gentleman with ESRD on regular hemodialysis. We describe the clinical presentation of this patient, the diagnostic process, the laboratory and imaging investigations, as well as the course of treatment. He positively responded to a 14-day course of Lopinavir-Ritonavir, Ribavirin, Azithromycin, and Hydroxychloroquine.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

A Hemodialysis Patient with Severe COVID-19 Pneumonia

Alalwan¹,

Taher²,

Al-Aradi³

2020

Cureus

View full text Add to dashboard Cite

show abstract

“…The transmission could happen by having close contact with confirmed positive cases with a percentage of 60.4% and without a contact with percentage of 10.9% (15). Coronavirus can be transmitted from human to human through close contact by splashes of droplets when coughing and sneezing of an infected person (10,12,(16)(17)(18) especially at close distances (19), and can spread through aerosols (16). In addition, it was also mentioned that SARS-CoV-2 can spread through the air especially in the air of rooms that have limited ventilation (19).…”

Section: Discussionmentioning

confidence: 99%

The Impact of Ambient Air Pollution Toward Coronavirus Disease 2019 (Covid19): A Literature Review

Nasikhah

Pawitra

2020

JKL

View full text Add to dashboard Cite

Introduction: WHO has announced coronavirus Disease 2019 (Covid19) as a global pandemic at the immune decline, one of which is due to chronic exposure to ambient air pollution. This literature review aims to describe the impact of ambient air pollution toward the risk of being infected by Covid19. Discussion: Covid19 can be found in a bat (host primer), and can be contagious through a person, also possible from pets. The symptoms that sufferers will perceive are fever, cough, diarrhea, myalgia, fatigue, headache, nausea, vomit, abdominal pain, loss of appetite, and some asymptomatic people. The body’s immunity affects a person’s susceptibility to Covid19 infection. The body’s immunity can be affected by ambient air pollution (with PM10, PM2,5, and O3 are the most pollutant in the air in various countries) for an extended period could be the reason for chronic illness (especially, respiratory tract) could reduce immune resistance. Furthermore, it might be happened on increasing at ACE2 activity and can cause increasing infected by Covid19. Prevention action can be done by contributing from all of the sectors at an observance in guarding, physical distancing, quarantine, and maintaining the ambient air quality in the future. Conclusion: Ambient air pollution must be considered as one effort to prevent chronic illness that can reduce immunity, which can increase the risk of being infected with Covid19. Furthermore, future studies will be carried out on ACE2 activity in people infected with Covid19 in order to get more valid results and following current conditions.

show abstract

“… 9 There is limited literature on the prevalence of COVID-19 in patients with end-stage kidney disease (ESKD) and how it compares to KTR. 10 , 11 In 1 Chinese retrospective study among ESKD patients, the prevalence of COVID-19 was 2.1%. 12 In another study from Italy, 15% (94/643) patients on maintenance dialysis were diagnosed with COVID-19.…”

Section: Epidemiology In Kidney Transplant Patientsmentioning

confidence: 99%

COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice

Kataria

Yakubu

Winstead

et al. 2020

Transplantation Direct

View full text Add to dashboard Cite

The novel severe acute respiratory syndrome coronavirus 2 was identified in the late 2019 as the cause of coronavirus disease 2019 (COVID-19), an acute respiratory viral illness. Patients with chronic underlying conditions may have an increased risk of morbidity and mortality from COVID-19. Kidney transplant recipients may be at a uniquely increased risk of serious complications from COVID-19 as compared to the general population because of a chronically immunosuppressed state and a high prevalence of comorbidities like diabetes, heart disease, and lung disease. Early data suggest that the mortality of patients on dialysis may be comparable to those with kidney transplants, although more research is needed. This concise review aims to describe the epidemiology of COVID-19 in kidney transplant recipients, manifestations, appropriate management, and clinical outcomes based on the available literature. Current evidence on many of the specific antiviral measures against COVID-19 has not shown a clear-cut benefit in smaller studies and the results of several ongoing larger clinical trials are awaited. In addition, we also highlight the impact of COVID-19 on kidney transplant center practice and volumes; potential living or deceased donors, recipients; and induction immunosuppression and surgical strategies.

show abstract

COVID-19 Pneumonia in a Hemodialysis Patient

Abstract: Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies on COVID-19 pneumonia outbreak were based on information from the general population.

Cited by 68 publications

References 11 publications

A Hemodialysis Patient with Severe COVID-19 Pneumonia

A Hemodialysis Patient with Severe COVID-19 Pneumonia

The Impact of Ambient Air Pollution Toward Coronavirus Disease 2019 (Covid19): A Literature Review

COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice

Contact Info

Product

Resources

About